In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors
Biomolecules · 2024
DOI: 10.3390/biom14050597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Boris Klebansky und 4 weiteren Autor:innen. Beteiligte Einrichtung: BioPredict Inc., 4 Adele Ave., Demarest, NY 07627, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Peptides, Programmed Cell Death 1 Receptor, Programmed Cell Death 1 Ligand 2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Current anti-cancer immune checkpoint therapy relies on antibodies that primarily target the PD-1/PD-L1(-L2) negative regulatory pathway. Although very successful in some cases for certain cancers, these antibodies do not help most patients who, presumably, should benefit from this type of therapy. Therefore, an unmet clinical need for novel, more effective drugs targeting immune checkpoints remains. We have developed a series of high-potency peptide inhibitors interfering with PD-1/PD-L1(-L2) protein–protein interaction. Our best peptide inhibitors are 12 and 14 amino acids long and show sub-micromolar IC50 inhibitory activity in the in vitro assay. The positioning of the peptides within the PD-1 binding site is explored by extensive modeling. It is further supported by 2D NMR studies of PD-1/peptide complexes. These results reflect substantial progress in the development of immune checkpoint inhibitors using peptidomimetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BioPredict Inc., 4 Adele Ave., Demarest, NY 07627, USA.
- SibTech Inc., 115A Commerce Drive, Brookfield, CT 06804, USA.
- Center for Open Research Resources & Equipment, University of Connecticut, Storrs, CT 06269-3060, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269-3092, USA.
ORCID-Profile: Olga Vinogradova
Zitieren
APA
Klebansky, B., Backer, M., Gorbatyuk, V., Vinogradova, O., & Backer, J. (2024). In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors. Biomolecules. https://doi.org/10.3390/biom14050597
Vancouver
Klebansky B, Backer M, Gorbatyuk V, Vinogradova O, Backer J. In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors. Biomolecules. 2024. doi:10.3390/biom14050597
BibTeX
@article{Klebansky2024,
author = {Klebansky, Boris and Backer, Marina and Gorbatyuk, Vitaliy and Vinogradova, Olga and Backer, Joseph},
title = {In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14050597}
}
EUVIMED